BURROWS SCOTT L (Chief Financial Officer) sold 7.1% of their position (7.50K shares) of SPYRE THERAPEUTICS, INC. on the open market
Open‑market sale worth $658.0K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 7/3/2026ACC: 0001636282-26-000088
Officer· Chief Financial Officer
Since Mar 2026
-7.50K
Net shares
Net seller
$658.0K
Total sold
2
Open market trades
0B · 2S
4
Total transactions
7.50K acquired · 15K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
+7.50K
Price / share
$14.50
Trade value
$108.75K
% of position
7.7%
7/1/2026
97.99K→105.49K
Common Stock
Direct
Shares
−5.78K
Price / share
$87.55
Trade value
$505.60K
% of position
5.5%
7/1/2026
105.49K→99.72K
Common Stock
Direct
Shares
−1.73K
Price / share
$88.37
Trade value
$152.44K
% of position
1.7%
7/1/2026
99.72K→97.99K
Total
Net shares
+0.00
Net value
-$549.29K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/1/2026 | M · Option Exercise | +7.50K | $14.50 | $108.75K | 7.7% | 97.99K | 105.49K |
| Common Stock Direct | 7/1/2026 | S · Sale | −5.78K | $87.55 | $505.60K | 5.5% | 105.49K | 99.72K |
| Common Stock Direct | 7/1/2026 | S · Sale | −1.73K | $88.37 | $152.44K | 1.7% | 99.72K | 97.99K |
| Total | +0.00 | -$549.29K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
7.50K shares
Shares
−7.50K
Strike price
14.50
Held after
352.36K
Exercisable
—
7/1/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock7.50K shares | 7/1/2026 | M · Option Exercise | −7.50K | 14.50 | — | 352.36K |